The Cue Biopharma platform was developed out of the laboratory of Steven Almo, Ph.D., Chair of the Department of Biochemistry at Albert Einstein College of Medicine/Montefiore Medical Center. Dr. Almo, with co-founders Ron Seidel III, Ph.D., Executive Vice President, Head of Research and Development and Rudy Chaparro, Ph.D. Executive Vice President, Head of Immunology, pioneered the work that led to Cue Biopharma’s Immuno-STAT platform as part of a five-year, Specialized Center grant from the National Institutes of Health (NIH). This funding enabled the technology to be built into an industry-scale drug design platform capable of rapid and efficient molecular prototyping and development. Cue Biopharma is leveraging these design capabilities in its discovery efforts.

Founders-Ron-Seidel

Ronald D. Seidel III, Ph.D.

Executive Vice President, Head of Research and Development
Founders-Steven-Almo

Steven Almo, Ph.D.

Co-Founder and Chair
Founders-Rudy-Chaparro

Rodolfo J. Chaparro, Ph.D.

Executive Vice President, Head of Immunology